{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:05:32Z","timestamp":1788584732238,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T00:00:00Z","timestamp":1709424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T00:00:00Z","timestamp":1709424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11418-023-01777-9","type":"journal-article","created":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T16:01:36Z","timestamp":1709481696000},"page":"474-487","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Protopanaxadiol improves lupus nephritis by regulating the PTX3\/MAPK\/ERK1\/2 pathway"],"prefix":"10.1007","volume":"78","author":[{"given":"Zhenyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangting","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baifang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6245-7450","authenticated-orcid":false,"given":"Huaying","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,3]]},"reference":[{"key":"1777_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","volume":"6","author":"HJ Anders","year":"2020","unstructured":"Anders HJ, Saxena R, Zhao MH, Parodis I, Salmon JE, Mohan C (2020) Lupus nephritis. Nat Rev Dis Primers 6:7. https:\/\/doi.org\/10.1038\/s41572-019-0141-9","journal-title":"Nat Rev Dis Primers"},{"key":"1777_CR2","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s40265-022-01715-1","volume":"82","author":"M Kostopoulou","year":"2022","unstructured":"Kostopoulou M, Pitsigavdaki S, Bertsias G (2022) Lupus nephritis: improving treatment options. Drugs 82:735\u2013748. https:\/\/doi.org\/10.1007\/s40265-022-01715-1","journal-title":"Drugs"},{"key":"1777_CR3","doi-asserted-by":"publisher","first-page":"v39","DOI":"10.1093\/rheumatology\/keaa381","volume":"59","author":"M Gasparotto","year":"2020","unstructured":"Gasparotto M, Gatto M, Binda V, Doria A, Moroni G (2020) Lupus nephritis: clinical presentations and outcomes in the 21st century. Rheumatology (Oxford) 59:v39\u2013v51. https:\/\/doi.org\/10.1093\/rheumatology\/keaa381","journal-title":"Rheumatology (Oxford)"},{"key":"1777_CR4","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/s41467-020-15986-3","volume":"11","author":"S Stanley","year":"2020","unstructured":"Stanley S, Vanarsa K, Soliman S, Habazi D, Pedroza C, Gidley G, Zhang T, Mohan S, Der E, Suryawanshi H, Tuschl T, Buyon J, Putterman C, Mok CC, Petri M, Saxena R, Mohan C (2020) Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities. Nat Commun 11:2197. https:\/\/doi.org\/10.1038\/s41467-020-15986-3","journal-title":"Nat Commun"},{"key":"1777_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/MAJ.0b013e31827f4ee3","volume":"346","author":"N Maroz","year":"2013","unstructured":"Maroz N, Segal MS (2013) Lupus nephritis and end-stage kidney disease. Am J Med Sci 346:319\u2013323. https:\/\/doi.org\/10.1097\/MAJ.0b013e31827f4ee3","journal-title":"Am J Med Sci"},{"key":"1777_CR6","doi-asserted-by":"publisher","first-page":"11555","DOI":"10.1002\/jcp.27810","volume":"234","author":"JX Liu","year":"2019","unstructured":"Liu JX, Feng XJ, Tian Y, Wang KX, Gao F, Yang L, Li HB, Tian YX, Yang R, Zhao L, Miao XY, Huang J, Liu QJ, Zhang W, Li YZ, Wang CL, Duan HJ, Liu SX (2019) Knockdown of TRIM27 expression suppresses the dysfunction of mesangial cells in lupus nephritis by FoxO1 pathway. J Cell Physiol 234:11555\u201311566. https:\/\/doi.org\/10.1002\/jcp.27810","journal-title":"J Cell Physiol"},{"key":"1777_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/BOR.0000000000000777","volume":"33","author":"A Chang","year":"2021","unstructured":"Chang A, Clark MR, Ko K (2021) Cellular aspects of the pathogenesis of lupus nephritis. Curr Opin Rheumatol 33:197\u2013204. https:\/\/doi.org\/10.1097\/BOR.0000000000000777","journal-title":"Curr Opin Rheumatol"},{"key":"1777_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11926-021-01048-0","volume":"23","author":"TK Nowling","year":"2022","unstructured":"Nowling TK (2022) Mesangial cells in lupus nephritis. Curr Rheumatol Rep 23:83. https:\/\/doi.org\/10.1007\/s11926-021-01048-0","journal-title":"Curr Rheumatol Rep"},{"key":"1777_CR9","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1681\/ASN.2008050549","volume":"20","author":"D Schlondorff","year":"2009","unstructured":"Schlondorff D, Banas B (2009) The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 20:1179\u20131187. https:\/\/doi.org\/10.1681\/ASN.2008050549","journal-title":"J Am Soc Nephrol"},{"key":"1777_CR10","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10875-013-9879-0","volume":"33","author":"MM Speeckaert","year":"2013","unstructured":"Speeckaert MM, Speeckaert R, Carrero JJ, Vanholder R, Delanghe JR (2013) Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease. J Clin Immunol 33:881\u2013890. https:\/\/doi.org\/10.1007\/s10875-013-9879-0","journal-title":"J Clin Immunol"},{"key":"1777_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/03009742.2016.1244288","volume":"46","author":"T Weitoft","year":"2017","unstructured":"Weitoft T, Larsson A, Saxne T, Manivel VA, Lysholm J, Knight A, Ronnelid J (2017) Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies. Scand J Rheumatol 46:346\u2013352. https:\/\/doi.org\/10.1080\/03009742.2016.1244288","journal-title":"Scand J Rheumatol"},{"key":"1777_CR12","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.3892\/ijmm.2018.3562","volume":"41","author":"BD Wang","year":"2018","unstructured":"Wang BD, Luo YK, Zhou XS, Li RS (2018) Trifluoperazine induces apoptosis through the upregulation of Bax\/Bcl-2 and downregulated phosphorylation of AKT in mesangial cells and improves renal function in lupus nephritis mice. Int J Mol Med 41:3278\u20133286. https:\/\/doi.org\/10.3892\/ijmm.2018.3562","journal-title":"Int J Mol Med"},{"key":"1777_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/bs.ircmb.2016.12.001","volume":"332","author":"SK Devarapu","year":"2017","unstructured":"Devarapu SK, Lorenz G, Kulkarni OP, Anders HJ, Mulay SR (2017) Cellular and molecular mechanisms of autoimmunity and lupus nephritis. Int Rev Cell Mol Biol 332:43\u2013154. https:\/\/doi.org\/10.1016\/bs.ircmb.2016.12.001","journal-title":"Int Rev Cell Mol Biol"},{"key":"1777_CR14","doi-asserted-by":"publisher","first-page":"354014","DOI":"10.1155\/2015\/354014","volume":"2015","author":"R Assandri","year":"2015","unstructured":"Assandri R, Monari M, Colombo A, Dossi A, Montanelli A (2015) Pentraxin 3 plasma levels and disease activity in systemic lupus erythematosus. Autoimmune Dis 2015:354014. https:\/\/doi.org\/10.1155\/2015\/354014","journal-title":"Autoimmune Dis"},{"key":"1777_CR15","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1002\/ptr.6430","volume":"33","author":"Y Liu","year":"2019","unstructured":"Liu Y, Yu C, Ji K, Wang XK, Li X, Xie H, Wang YQ, Huang YT, Qi D, Fan HY (2019) Quercetin reduces TNF-alpha-induced mesangial cell proliferation and inhibits PTX3 production: involvement of NF-kappaB signaling pathway. Phytother Res 33:2401\u20132408. https:\/\/doi.org\/10.1002\/ptr.6430","journal-title":"Phytother Res"},{"key":"1777_CR16","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3389\/fimmu.2018.02173","volume":"9","author":"JA Marschner","year":"2018","unstructured":"Marschner JA, Mulay SR, Steiger S, Anguiano L, Zhao Z, Boor P, Rahimi K, Inforzato A, Garlanda C, Mantovani A, Anders HJ (2018) The long pentraxin PTX3 is an endogenous inhibitor of hyperoxaluria-related nephrocalcinosis and chronic kidney disease. Front Immunol 9:2173. https:\/\/doi.org\/10.3389\/fimmu.2018.02173","journal-title":"Front Immunol"},{"key":"1777_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.fct.2017.07.019","volume":"107","author":"C Mancuso","year":"2017","unstructured":"Mancuso C, Santangelo R (2017) Panax ginseng and Panax quinquefolius: from pharmacology to toxicology. Food Chem Toxicol 107:362\u2013372. https:\/\/doi.org\/10.1016\/j.fct.2017.07.019","journal-title":"Food Chem Toxicol"},{"key":"1777_CR18","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.bcp.2010.06.023","volume":"80","author":"LW Qi","year":"2010","unstructured":"Qi LW, Wang CZ, Yuan CS (2010) American ginseng: potential structure\u2013function relationship in cancer chemoprevention. Biochem Pharmacol 80:947\u2013954. https:\/\/doi.org\/10.1016\/j.bcp.2010.06.023","journal-title":"Biochem Pharmacol"},{"key":"1777_CR19","first-page":"106","volume":"40","author":"XS Xie","year":"2009","unstructured":"Xie XS, Liu HC, Fan JM, Li HJ (2009) Effects of ginsenoside Rb1 on TGF-beta1 induced p47phox expression and extracellular matrix accumulation in rat renal tubular epethelial cells. Sichuan da xue xue bao Yi xue ban J Sichuan Univ Med Sci Ed 40:106\u2013110","journal-title":"Sichuan da xue xue bao Yi xue ban J Sichuan Univ Med Sci Ed"},{"key":"1777_CR20","doi-asserted-by":"publisher","first-page":"113500","DOI":"10.1016\/j.jep.2020.113500","volume":"267","author":"Y Li","year":"2021","unstructured":"Li Y, Hou JG, Liu Z, Gong XJ, Hu JN, Wang YP, Liu WC, Lin XH, Wang Z, Li W (2021) Alleviative effects of 20 (R)-Rg3 on HFD\/STZ-induced diabetic nephropathy via MAPK\/NF-\u03baB signaling pathways in C57BL\/6 mice. J Ethnopharmacol 267:113500. https:\/\/doi.org\/10.1016\/j.jep.2020.113500","journal-title":"J Ethnopharmacol"},{"key":"1777_CR21","doi-asserted-by":"publisher","first-page":"104746","DOI":"10.1016\/j.phrs.2020.104746","volume":"155","author":"YY Zhu","year":"2020","unstructured":"Zhu YY, Zhu CH, Yang HX, Deng JJ, Fan DD (2020) Protective effect of ginsenoside Rg5 against kidney injury via inhibition of NLRP3 inflammasome activation and the MAPK signaling pathway in high-fat diet\/streptozotocin-induced diabetic mice. Pharmacol Res 155:104746. https:\/\/doi.org\/10.1016\/j.phrs.2020.104746","journal-title":"Pharmacol Res"},{"key":"1777_CR22","first-page":"776","volume":"29","author":"YL You","year":"2009","unstructured":"You YL, Ling C, Feng YL (2009) Efficacy of combined therapy with ginsenosides and prednisone in treating systemic lupus erythematosus\u2014a randomized, controlled and double-blinded trial. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi Jiehe Zazhi Chin J Integr Tradit West Med 29:776\u2013779","journal-title":"Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi Jiehe Zazhi Chin J Integr Tradit West Med"},{"key":"1777_CR23","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3736\/jcim20100806","volume":"8","author":"YL You","year":"2010","unstructured":"You YL, Feng YL, Cai Q, Guan JL, Zhang LL, Xu MJ, Xu X, Ling CQ (2010) Efficacy of ginsenosides combined with prednisone in patients with systemic lupus erythematosus: a prospective, randomized, double-blind, placebo-controlled trial. Zhong xi yi jie he xue bao J Chin Integr Med 8:762\u2013766. https:\/\/doi.org\/10.3736\/jcim20100806","journal-title":"Zhong xi yi jie he xue bao J Chin Integr Med"},{"key":"1777_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jgr.2018.10.006","volume":"44","author":"MK Choi","year":"2020","unstructured":"Choi MK, Jin S, Jeon JH, Kang WY, Seong SJ, Yoon YR, Han YH, Song IS (2020) Tolerability and pharmacokinetics of ginsenosides Rb1, Rb2, Rc, Rd, and compound K after single or multiple administration of red ginseng extract in human beings. J Ginseng Res 44:229\u2013237. https:\/\/doi.org\/10.1016\/j.jgr.2018.10.006","journal-title":"J Ginseng Res"},{"key":"1777_CR25","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.jgr.2018.06.001","volume":"43","author":"HJ Won","year":"2019","unstructured":"Won HJ, Kim HI, Park T, Kim H, Jo K, Jeon H, Ha SJ, Hyun JM, Jeong A, Kim JS (2019) Non-clinical pharmacokinetic behavior of ginsenosides. J Ginseng Res 43:354\u2013360. https:\/\/doi.org\/10.1016\/j.jgr.2018.06.001","journal-title":"J Ginseng Res"},{"key":"1777_CR26","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/j.1745-7254.2008.00868.x","volume":"29","author":"C Cf","year":"2008","unstructured":"Cf C, Wf C, Jt Z (2008) Comparison of the pharmacological effects of Panax ginseng and Panax quinquefolium. Acta Pharmacol Sin 29:1103\u20131108. https:\/\/doi.org\/10.1111\/j.1745-7254.2008.00868.x","journal-title":"Acta Pharmacol Sin"},{"key":"1777_CR27","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2116\/analsci.26.749","volume":"26","author":"MH Han","year":"2010","unstructured":"Han MH, Chen J, Chen SL, Wang XT (2010) Development of a UPLC-ESI-MS\/MS assay for 20 (S)-protopanaxadiol and pharmacokinetic application of its two formulations in rats. Anal Sci 26:749\u2013753. https:\/\/doi.org\/10.2116\/analsci.26.749","journal-title":"Anal Sci"},{"key":"1777_CR28","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jpba.2008.09.045","volume":"48","author":"HC Ren","year":"2008","unstructured":"Ren HC, Sun JG, Wang GJ, A JY, Xie HT, Zha WB, Yan B, Sun FZ, Hao HP, Gu SH (2008) Sensitive determination of 20 (S)-protopanaxadiol in rat plasma using HPLC\u2013APCI-MS: application of pharmacokinetic study in rats. J Pharm Biomed Anal 48:1476\u20131480. https:\/\/doi.org\/10.1016\/j.jpba.2008.09.045","journal-title":"J Pharm Biomed Anal"},{"key":"1777_CR29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1681\/ASN.2010010098","volume":"22","author":"I Loeffler","year":"2011","unstructured":"Loeffler I, Hopfer U, Koczan D, Wolf G (2011) Type VIII collagen modulates TGF-beta1-induced proliferation of mesangial cells. J Am Soc Nephrol 22:649\u2013663. https:\/\/doi.org\/10.1681\/ASN.2010010098","journal-title":"J Am Soc Nephrol"},{"key":"1777_CR30","doi-asserted-by":"publisher","first-page":"102871","DOI":"10.1016\/j.jaut.2022.102871","volume":"132","author":"C Yu","year":"2022","unstructured":"Yu C, Li P, Dang X, Zhang X, Mao YH, Chen XM (2022) Lupus nephritis: new progress in diagnosis and treatment. J Autoimmun 132:102871. https:\/\/doi.org\/10.1016\/j.jaut.2022.102871","journal-title":"J Autoimmun"},{"key":"1777_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-immunol-030409-101305","volume":"28","author":"B Bottazzi","year":"2010","unstructured":"Bottazzi B, Doni A, Garlanda C, Mantovani A (2010) An integrated view of humoral innate immunity: pentraxins as a paradigm. Annu Rev Immunol 28:157\u2013183. https:\/\/doi.org\/10.1146\/annurev-immunol-030409-101305","journal-title":"Annu Rev Immunol"},{"key":"1777_CR32","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1159\/000368778","volume":"165","author":"S Jaillon","year":"2014","unstructured":"Jaillon S, Bonavita E, Gentile S, Rubino M, Laface I, Garlanda C, Mantovani A (2014) The long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases. Int Arch Allergy Immunol 165:165\u2013178. https:\/\/doi.org\/10.1159\/000368778","journal-title":"Int Arch Allergy Immunol"},{"key":"1777_CR33","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1084\/jem.20150282","volume":"213","author":"A Chorny","year":"2016","unstructured":"Chorny A, Casas-Recasens S, Sintes J, Shan M, Polentarutti N, Garcia-Escudero R, Walland AC, Yeiser JR, Cassis L, Carrillo J, Puga I, Cunha C, Bastos H, Rodrigues F, Lacerda JF, Morais A, Dieguez-Gonzalez R, Heeger PS, Salvatori G, Carvalho A, Garcia-Sastre A, Blander JM, Mantovani A, Garlanda C, Cerutti A (2016) The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells. J Exp Med 213:2167\u20132185. https:\/\/doi.org\/10.1084\/jem.20150282","journal-title":"J Exp Med"},{"key":"1777_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s11060-016-2168-z","volume":"129","author":"JN Tung","year":"2016","unstructured":"Tung JN, Ko CP, Yang SF, Cheng CW, Chen PN, Chang CY, Lin CL, Yang TF, Hsieh YH, Chen KC (2016) Inhibition of pentraxin 3 in glioma cells impairs proliferation and invasion in vitro and in vivo. J Neurooncol 129:201\u2013209. https:\/\/doi.org\/10.1007\/s11060-016-2168-z","journal-title":"J Neurooncol"},{"key":"1777_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12016-015-8476-9","volume":"49","author":"N Bassi","year":"2015","unstructured":"Bassi N, Del Prete D, Ghirardello A, Gatto M, Ceol M, Zen M, Bettio S, Mantovani A, Iaccarino L, Punzi L, Doria A (2015) PTX3, anti-PTX3, and anti-C1q autoantibodies in lupus glomerulonephritis. Clin Rev Allergy Immunol 49:217\u2013226. https:\/\/doi.org\/10.1007\/s12016-015-8476-9","journal-title":"Clin Rev Allergy Immunol"},{"key":"1777_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jgr.2017.01.011","volume":"41","author":"HL Lee","year":"2017","unstructured":"Lee HL, Kang KS (2017) Protective effect of ginsenoside Rh3 against anticancer drug-induced apoptosis in LLC-PK1 kidney cells. J Ginseng Res 41:227\u2013231. https:\/\/doi.org\/10.1016\/j.jgr.2017.01.011","journal-title":"J Ginseng Res"},{"issue":"3","key":"1777_CR37","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3390\/biom10030444","volume":"10","author":"DS Im","year":"2020","unstructured":"Im DS (2020) Pro-resolving effect of ginsenosides as an anti-inflammatory mechanism of Panax ginseng. Biomolecules 10(3):444. https:\/\/doi.org\/10.3390\/biom10030444","journal-title":"Biomolecules"},{"key":"1777_CR38","doi-asserted-by":"publisher","first-page":"202","DOI":"10.4049\/jimmunol.1900284","volume":"205","author":"CY Wu","year":"2020","unstructured":"Wu CY, Hua KF, Hsu WH, Suzuki Y, Chu LJ, Lee YC, Takahata A, Lee SL, Wu CC, Nikolic-Paterson DJ, Ka SM, Chen A (2020) IgA nephropathy benefits from compound K treatment by inhibiting NF-kappaB\/NLRP3 inflammasome and enhancing autophagy and SIRT1. J Immunol 205:202\u2013212. https:\/\/doi.org\/10.4049\/jimmunol.1900284","journal-title":"J Immunol"},{"key":"1777_CR39","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1248\/bpb.25.743","volume":"25","author":"EA Bae","year":"2002","unstructured":"Bae EA, Choo MK, Park EK, Park SY, Shin HY, Kim DH (2002) Metabolism of ginsenoside Rc by human intestinal bacteria and its related antiallergic activity. Biol Pharm Bull 25:743\u2013747. https:\/\/doi.org\/10.1248\/bpb.25.743","journal-title":"Biol Pharm Bull"},{"key":"1777_CR40","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1007\/s10753-016-0337-z","volume":"39","author":"ZC Yang","year":"2016","unstructured":"Yang ZC, Liu Y (2016) Hypoxia-inducible factor-1alpha and autoimmune lupus, arthritis. Inflammation 39:1268\u20131273. https:\/\/doi.org\/10.1007\/s10753-016-0337-z","journal-title":"Inflammation"},{"key":"1777_CR41","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.toxicon.2021.06.005","volume":"199","author":"E Darbuka","year":"2021","unstructured":"Darbuka E, Gurkaslar C, Yaman I (2021) Ochratoxin A induces ERK1\/2 phosphorylation-dependent apoptosis through NF-kappaB\/ERK axis in human proximal tubule HK-2 cell line. Toxicon 199:79\u201386. https:\/\/doi.org\/10.1016\/j.toxicon.2021.06.005","journal-title":"Toxicon"},{"key":"1777_CR42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.niox.2010.12.010","volume":"25","author":"N Olson","year":"2011","unstructured":"Olson N, Vliet AVD (2011) Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease. Nitric Oxide 25:125\u2013137. https:\/\/doi.org\/10.1016\/j.niox.2010.12.010","journal-title":"Nitric Oxide"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-023-01777-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-023-01777-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-023-01777-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T08:21:15Z","timestamp":1715934075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11418-023-01777-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1777"],"URL":"https:\/\/doi.org\/10.1007\/s11418-023-01777-9","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"value":"1340-3443","type":"print"},{"value":"1861-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,3]]},"assertion":[{"value":"30 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflicts of interest in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}